New Canadian Study of Cannabis with Alzheimer’s

The drug trial is being funded by a £300,000 ($386,882) grant from Alzheimer’s Research UK and will explore the effectiveness of Sativexa cannabis-derived drug currently used to reduce muscle stiffness and spasms in MS patientsin reducing symptoms of aggression and agitation. The researchers are looking to recruit 60 participants with Alzheimer’s between the ages of 55 and 90 who experience agitation and aggression. If successful, the trial will be followed up with a larger study.

Leave a Reply

Your email address will not be published. Required fields are marked *